Tickerplace logo

Tickerplace

Immunic, Inc. logo

IMUXImmunic, Inc.

IMUX Stock Price, Valuation & Chart | Immunic, Inc.

Compare
$6.970-0.13 (-1.83%)

At close · 16 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Biotechnology
OverviewFinancialsDividendsRatios

IMUX Historical price chart

IMUX Key Stats

Market Capitalization95.10M
PE Ratio-2.67
EPS-2.61
Trading Volume366.16K
Today's High/Low7.22/6.81
Dividend Yield0.00
52 Week High/Low17.43/5.06
Shares Outstanding13.64M
IMUX Financial Statement
IMUX Analyst ratings
IMUX Analysis & performance metrics

IMUX Company profile

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune…

IMUX Management team

Management
Jason Tardio M.B.A.COO
Chief Operating Officer & President
Daniel Vitt Ph.D.CEO
Chief Executive Officer & Director
Werner Gladdines
Chief Development Officer
Duane D. Nash J.D., M.B.A., M.D.
Executive Chairman
Glenn Whaley CPACFO
Chief Financial Officer
Hella Kohlhof
Chief Scientific Officer
Andreas Muehler M.D., Ph.D.
Chief Medical Officer
Jessica Breu
Head of Investor Relations & Communications
Total 8 executives

IMUX Frequently asked questions

What is Immunic, Inc. (IMUX) Stock Price?

Current stock price of Immunic, Inc. (IMUX) stock is $6.970. The stock price is -1.83% lower in the session. The intraday range can be seen from this page. Volume of Immunic, Inc. (IMUX) stock is 366.16K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Immunic, Inc. (IMUX) stock price going up or down today?

The stock price of Immunic, Inc. (IMUX) can change with earnings, company news, and overall market sentiment. Immunic, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Immunic, Inc. stock expensive at its current price?

Whether Immunic, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for IMUX on this page is -2.67. EPS on this page is -2.61. Compare those figures with peers and growth expectations before deciding if the current Immunic, Inc. price is justified.

How has the stock price of Immunic, Inc. (IMUX) performed historically?

Historical performance for Immunic, Inc. (IMUX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how IMUX reacted to past earnings and market events.

Should I buy Immunic, Inc. (IMUX) stock, at this price?

Buying Immunic, Inc. (IMUX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.